创伤性脑损伤的恢复轨迹与长期结局:Citicoline脑损伤治疗临床试验3期数据的二次分析
该研究对COBRIT试验3期数据行二次分析,评估伤后30、90、180天的恢复轨迹与结局。伤后6个月时,重型、中型和复杂轻型TBI的有利结局率分别为57%、86%和93%,且恢复轨迹在6个月时尚未进入平台期,提示改善可能持续至6个月之后。
要点
- 伤后6个月有利结局率:重型TBI 57%,中型86%,复杂轻型93%。
- 伤后1个月时植物状态(GOS-E评分2分)者中,18%在6个月时改善为有利结局。
- 所有组别从伤后1个月至6个月均有大幅改善,恢复轨迹在6个月时尚未进入平台期。
核心结论
- 在COBRIT试验的二次分析中,复杂轻型和中型TBI患者6个月时多数达到GOS-E有利结局,重型TBI患者中超过半数也达到有利结局。
- 伤后1个月处于植物状态(GOS-E评分2分)的受试者中,18%在6个月时改善为有利结局。
- 所有组别从1个月至6个月均有实质性改善,且这种改善可能在6个月后继续。
- TBI临床试验应考虑采用重复测量的恢复曲线评估结局,因为任意的单时间点结局判定可能低估TBI治疗效应。
研究设计与样本
- 对3期Citicoline脑损伤治疗(COBRIT)试验进行二次分析,评估伤后30天、90天和180天的恢复轨迹与长期结局。
- GOS-E评分≥5分视为有利结局。
- 采用Pearson χ2分析,P值0.05视为显著;采用局部加权多项式回归模型以非线性方式建模恢复轨迹。
主要发现
- 6个月随访时有利结局率:重型TBI 57%,中型TBI 86%,复杂轻型TBI 93%。
- 伤后1个月初始随访时不利结局率:重型TBI 85%,中型TBI 57%,复杂轻型TBI 21%,这些不利结局常转为有利结局。
- 伤后1个月处于植物状态(GOS-E评分2分)的受试者中,18%在伤后6个月改善为有利结局。
- 恢复轨迹在6个月时尚未进入平台期,提示伤后6个月之后仍可能进一步改善。
临床怎么用
- 作者认为,TBI临床试验应考虑采用重复测量的恢复曲线评估结局,因为任意的单时间点结局判定可能低估TBI治疗效应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prospects for recovery after traumatic brain injury (TBI) are often underestimated, potentially leading to withdrawal of care in the comatose TBI patient who may ultimately have a favorable outcome with aggressive care. Outcomes and trajectories of recovery in a large series of patients with TBI were evaluated at 30, 90, and 180 days postinjury. METHODS: A secondary analysis of the phase 3 Citicoline Brain Injury Treatment (COBRIT) trial was performed analyzing recovery trajectories and long-term outcomes at 30, 90, and 180 days postinjury. A Glasgow Outcome Scale-Extended (GOS-E) score of 5 or higher was considered favorable. Pearson χ2 analysis was used, and a P value of 0.05 was considered significant. A locally weighted, polynomial regression model was used to model recovery trajectories in a nonlinear fashion. RESULTS: Subjects with TBI in the COBRIT trial had high rates of favorable outcome (57% of severe TBI, 86% of moderate TBI, and 93% of complicated mild TBI) at 6-month follow-up. These favorable outcomes often converted from high rates of unfavorable outcome at initial 1-month follow-up (85% of severe TBI, 57% of moderate TBI, and 21% of complicated mild TBI). Recovery trajectories had not plateaued at 6 months, suggesting that further improvement occurs beyond 6 months postinjury. CONCLUSIONS: In this secondary analysis of the COBRIT trial, most patients had favorable outcomes by the GOS-E at 6 months postinjury in all complicated mild and moderate TBI groups, with over half of patients with severe TBI achieving a favorable outcome as well. Of subjects in a vegetative state (GOS-E score 2) at 1 month postinjury, 18% improved to a favorable outcome by 6 months postinjury. There was substantial improvement in all groups from 1 to 6 months, and this improvement may continue beyond 6 months. Clinical trials in TBI should consider recovery curves with repeated measures to assess outcomes because arbitrary single-moment outcome determination likely underestimates treatment effect in TBI care.
引用
- Puffer RC, Yue JK, Mesley M, et al. Recovery Trajectories and Long-Term Outcomes in Traumatic Brain Injury: A Secondary Analysis of the Phase 3 Citicoline Brain Injury Treatment Clinical Trial. World Neurosurg. 2019. PMID: 30763755. doi:10.1016/j.wneu.2019.01.207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。